key: cord-0853854-7nqlztw8 authors: Rosman, Lindsey; Armbruster, Tiffany; Kyazimzade, Sayyad; Tugaoen, Zachary; Mazzella, Anthony J.; Deyo, Zack; Walker, Jennifer; Machineni, Sriram; Gehi, Anil title: Effect of a virtual self‐management intervention for atrial fibrillation during the outbreak of COVID‐19 date: 2021-02-17 journal: Pacing Clin Electrophysiol DOI: 10.1111/pace.14188 sha: 65e3e9cf66953dd201dd29c30500e92750d6c17d doc_id: 853854 cord_uid: 7nqlztw8 BACKGROUND: As the pandemic continues to unfold, effective, technology‐based solutions are needed to help patients with atrial fibrillation (AF) maintain their health and well‐being during the outbreak of COVID‐19. METHODS: This single‐center, pilot study investigated the effects of a 4‐week (eight sessions) virtual AF self‐management program. Questionnaires were completed at baseline and 1 week after the intervention, and assessed AF knowledge, adherence to self‐management behaviors, mental health, physical function, and disease‐specific quality of life in patients with AF. Secondary outcomes included knowledge of COVID‐19, intervention, acceptability, and satisfaction. RESULTS: Of 68 patients who completed baseline questionnaires, 57 participated in the intervention and were included in the analysis (mean age of 73.4 ± 10.0 years, 60% male). Adherence to AF self‐monitoring behaviors, including monitoring their heart rate (p < .001), heart rhythm (p = .003), and blood pressure (p = .013) were significantly improved at the end of the intervention compared with baseline. Symptom identification (p = .007) and management (p < .001) also improved. Reductions in sleep disturbance (p < .001), anxiety (p = .014), and depression (p = .046) were also observed. Misinformation and inaccurate beliefs about COVID‐19 were significantly reduced at the end of the intervention compared with baseline. CONCLUSIONS: This pilot study suggests that a virtual patient education program could have beneficial effects on adherence to guideline‐recommend self‐care of AF, emotional wellbeing, physical function, and knowledge of COVID‐19 in patients with AF. Future randomized studies in larger samples are needed to determine the clinical benefits of the intervention. Individuals meeting inclusion criteria were sent an invitation to participate in the intervention through the EHR-based patient portal. Patients who provided consent to participate were emailed a packet of information about the program and instructions to help troubleshoot technical issues. Patients did not receive compensation for completing study questionnaires or for participating in the intervention. The protocol and procedures were approved by the institutional review board at the University of North Carolina; all participants provided electronic informed consent. The AF-At-Home Program was developed to improve AF management by focusing on self-monitoring, skill development, and behavioral risk factor modification. The program included eight 1-h group sessions, occurring 2 days per week over 4 consecutive weeks and was delivered with a secure video-conferencing platform. Each session included 40 min of didactic instruction followed by 20 min of interactive group discussion and questions answered by the session leader. Sessions were led by a diverse group of health care professionals from cardiovascular electrophysiology, cardiac psychology, endocrinology, clinical pharmacy, and social work. Content was based on guideline-recommended topics for AF patient education 2 and included information on AF symptom recognition and management, therapeutic strategies, stroke prevention, behavioral strategies to mitigate lifestyle risk factors (healthy diet, physical activity, minimizing alcohol and other substances), comorbidity management (e.g., blood pressure monitoring and control, heart failure therapy), developing an action plan for acute AF exacerbations, and skills for reducing stress associated with AF (details of each session are provided in the Supplementary Appendix). In addition to standard AF patient education, sessions focused on enhancing coping strategies, activating personal resources, and equipping patients with the knowledge, tools, and skills they need to maintain their physical and emotional health during the pandemic (e.g., accessing routine care via telehealth, the importance of seeking medical care for acute cardiovascular symptoms, healthy eating during food shortages, and the psychological, social, and financial impact of the pandemic). To reinforce learning, patients were provided digital educational materials and website links to video recordings of the didactic portion of the session. Baseline demographic and clinical data were collected by medical chart abstraction for all study participants. Standard definitions 1, 2 and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes were used to obtain data on demographic characteristics, AF history, prior procedures, current medical therapies, general medical history, and lifestyle factors. Personnel who collected medical record data were blinded to study outcomes. Patients completed questionnaires at baseline (pre-intervention) and again 5 weeks later (1-week post-intervention). The primary outcomes for this study were AF-related health knowledge, adherence to guideline-recommended self-management behaviors, mental and physical health outcomes, and general and AF-specific quality of life. Secondary outcomes included self-reported knowledge of COVID-19 and assessment of intervention acceptability and satisfaction with the program. 2.3.1 AF knowledge and adherence to self-management behaviors A series of questions evaluated patients' knowledge and understanding of AF, adherence to self-management behaviors, and confidence in implementing self-management skills (details provided in Table S1 of the Supplementary Appendix). Items were similar to those used in prior studies of AF self-management behaviors. 19 Patients were asked to indicate the frequency of completing specific AF self-management behaviors and to rate their overall level of confidence in performing these behaviors using a Likert scale, with higher scores indicating greater adherence or confidence in completing the prescribed skill. Mental health and physical function Given the rapid spread of inaccurate or misleading medical information about COVID-19 during the pandemic, 23 immediately. In addition, patients were asked to indicate if they agree or disagree with the following statements: (5) "I would delay seeking care for acute symptoms of a heart attack or stroke due to fear of COVID-19" and (6) " If I had to go to the hospital for worsening cardiac symptoms, I worry that I would not get the medical care I need because of COVID-19." To further understand health information seeking behaviors among patients with AF during the pandemic, a separate question asked about their primary source of information on COVID-19 (television news, newspaper, social media [e.g., Twitter, Facebook], radio, smartphone app, magazines, family/friends, doctors/medical team). Acceptability and satisfaction with the program We determined that recruitment of at least 49 patients would provide a power of more than 80% to detect an effect of the intervention on PROMIS domain scores from pre to post intervention, with a twosided alpha level of 0.05, and a planned drop-out rate of 25% which is F I G U R E 1 Effects of the atrial fibrillation (AF)-at-home program on self-management skills in patients with AF [Color figure can be viewed at wileyonlinelibrary.com] the median dropout rate for studies of internet-based education and lifestyle interventions. 24 However, the decision was made to expand enrollment to accommodate a potentially higher dropout rate (≥50%) due to the pandemic. Study outcomes were analyzed separately among those who participated in at least one session of the intervention (program participants, n = 57) and those who attended zero sessions of the intervention but completed the questionnaire at both study baseline and followup (non-participants, n = 11) unless otherwise indicated. Categorical data were summarized using frequencies and percentages and continuous data are reported as mean ± SD. Wilcoxon signed rank test to examine secondary outcomes among program participants. The effect of intervention compliance was assessed using the Mann-Whitney U test. Program acceptability and satisfaction were also examined. Less than 1% of patients had missing data; these data were excluded from the analyses. A two-sided p value of less than .05 was considered significant. Analyses were performed with SAS version 9.4 (SAS Institute, Cary, NC, USA). Figure 1 was generated using R version 4.0 (R Foundation for Statistical Computing, Vienna, Austria). Sixty-eight patients consented to participate in the study and com- Baseline characteristics of the study population are shown in Table 1 . Most patients were older (mean age of 73.4 ± 10.0 years), white, males with paroxysmal AF, hypertension, hyperlipidemia, and had prescriptions for beta-blockers and direct oral anticoagulant (DOAC) therapies. Persons who participated in the AF-At-Home Program were more likely to have persistent or permanent AF, have a history of coronary artery disease and had a lower body mass index (BMI) than those who did not participate in the intervention. There were no positive cases of COVID-19 reported among study participants at follow-up. As shown in Table 3 , uncertainty and inaccurate information about COVID-19 was high at baseline among intervention participants. Very few patients reported that they would delay seeking medical care for acute cardiovascular symptoms due to fears of COVID-19 infection (7.0%). However, nearly one in five reported concerns about receiving sub-optimal care if they were hospitalized for AF during the pandemic. In addition, Figure S1 shows that patients with AF There was no correlation between the number of intervention sessions attended and the primary or secondary outcomes (data not shown). A majority of program participants (75%) reported improvements in AF knowledge and self-management skills after completing the AF-At Home-Program. Participants also reported feeling more confident in their ability to recognize symptoms and manage AF exacerbations (58.8% strongly agreed, 39.2% agreed) and more than two-thirds reported they were highly satisfied with the program. 27 Another study of a smartphone app for AF showed improvements in disease knowledge, medication adherence, and quality of life. 28 However, those studies were limited to specific subgroups of patients with AF and few apps have demonstrated adoption, reach, and sustainability after their initial evaluation, particularly among persons who are less-educated, lower income or from a minority background. 29 We extend this work by demonstrating the acceptability and preliminary efficacy of a structured AF self-management program that was adapted for rapid delivery to address the secondary health impacts of an ongoing public health emergency. We further demonstrate that such an intervention can be delivered 100% remotely, thereby minimizing the risk of COVID-19 exposure among health care providers and patients. The high percentage of women (40%) and older adults who participated in this study also suggests that the technologybased programs may facilitate access to underserved populations by overcoming traditional barriers to nonattendance (e.g., inadequate transportation, lack of insurance, and work obligations, and caregiver responsibilities). 30 In addition, although family involvement was not explicitly assessed in this study, we observed a high rate of participation among spouses and caregivers during the intervention. Family members often play a critical role in facilitating lifestyle modifications 31 and couples-based interventions have been shown to be more effective at improving cardiovascular risk factor management than programs that target only the patient. 32, 33 Thus, virtual models of AF care may have additional benefits that warrant further study. The intervention did not have an effect on AF-related quality of life. The absence of an effect on AF-related quality of life could have been TA B L E 2 Differences in primary outcomes at baseline and study follow-up Notes a :Data are presented as means ± SD. For PROMIS domains, a positive value represents worsening pain, pain interference, fatigue, sleep disturbance, depression, and anxiety and an improvement in physical functioning and ability to participate in social roles and activities. This intervention was specifically developed to address disruptions in medical services during the most acute phase of the COVID-19 pandemic, however, the need for safe, socially-distant interventions will remain during more "chronic" phases of the pandemic, and possibly for months even after a vaccine becomes available. It also remains to be seen whether these services can be adopted and implemented in routine care, and whether the AF-At-Home program is effective in populations with less access to technology, low health literacy, and persons living in rural communities, as these populations may be disproportionately affected by digital inequalities and disruption to routine care during a public health emergency. Further randomized clinical studies are also needed to quantify the impact of the AF-At-Home program on clinically meaningful outcomes such as reductions in thromboembolic events, and utilization of inpatient, outpatient, or emergency medical services, and to identify patients who would benefit from this type of technology-based intervention. This study is not without limitations. First, this study was conducted at an academic medical center with predominantly older, white patients with varying levels of AF knowledge, adherence and health literacy at baseline. Thus, the generalizability of these results to other patients with AF and to other types of organizations may be limited. The lack of randomization is another limitation of this study. Second, while we were able to examine within-subject changes in the primary outcomes among persons who did and did not participate in the intervention, the study did not include a pre-specified comparison condition (e.g., usual care) and was not powered to examine betweengroup differences in outcomes. Third, in response to the disruptions to routine care that occurred while stay-at-home orders were in place, the recruitment period was intentionally short (8 days). We recognize that this limits generalizability, but we felt that rapid, direct communication with patients was the priority. Nevertheless, this may have introduced a selection bias, as persons who regularly use technology may have responded to the study invitation in that timeframe. The reliance on self-report measures that are prone to social desirability bias may also have affected our results. Similarly, while specific changes in AF knowledge were evaluated, additional dimensions of disease knowledge and health behavior change should be examined in future studies (e.g., knowledge of anticoagulation, procedures, and preventative health behaviors). Fourth, as with any observational study, it is possible that residual confounding may have affected our results. Finally, this pilot study was too small and too short in duration to assess the effect of the intervention on meaningful clinical outcomes or adjust for important clinical covariates in our analyses. Well-designed trials are needed to clarify these issues and to determine the optimal frequency and timing of intervention sessions to maximize program value in routine clinical care. As the pandemic continues to unfold, effective, technology-based solutions are needed to help patients with AF maintain the health and wellbeing. Findings from this proof-of-concept study indicate that a The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Lindsey Rosman PhD https://orcid.org/0000-0002-0944-6864 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society Evidence for therapeutic patient education interventions to promote cardiovascular patient self-management: a scientific statement for healthcare professionals from the American Heart Association Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation Disease understanding in patients newly diagnosed with atrial fibrillation Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis Clinical features of patients infected with 2019 novel coronavirus in Wuhan COVID-19 and the cardiovascular system Secondary impact of the COVID-19 pandemic on patients with heart failure Quality of life in patients with atrial fibrillation: a systematic review Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence Triggering of symptomatic atrial fibrillation by negative emotion Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation Count me in: using a patient portal to minimize implicit bias in clinical research recruitment A survey of practices for the use of electronic health records to support research recruitment Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project PROMIS(®)-29 v2.0 profile physical and mental health summary scores Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) questionnaire in patients with atrial fibrillation Defining clinically important difference in the atrial fibrillation effect on quality-of-life score. Circ Cardiovasc Qual Outcomes Fear of coronavirus disease 2019-An emerging cardiac risk Dropout is a problem in lifestyle intervention programs for overweight and obese infertile women: a systematic review Effect size estimates: current use, calculations, and interpretation Home-based versus centrebased cardiac rehabilitation Effectiveness and usability of an online tailored education platform for atrial fibrillation patients undergoing a direct current cardioversion or pulmonary vein isolation Review of mobile applications for the detection and management of atrial fibrillation Bridging the global digital health divide for cardiovascular disease Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative Concordance of cardiovascular risk factors and behaviors in a multiethnic US Nationwide cohort of married couples and domestic partners Let's move:' a systematic review of spouse-involved interventions to promote physical activity Patient plus partner trial: a randomized controlled trial of 2 interventions to improve outcomes after an initial implantable cardioverter-defibrillator Defining a mobile health roadmap for cardiovascular health and disease Medical misinformation: vet the message! The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review Effect of a virtual self-management intervention for atrial fibrillation during the outbreak of COVID-19